Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03524391
Other study ID # NMP/10123
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 12, 2016
Est. completion date February 25, 2017

Study information

Verified date May 2018
Source NMP Medical Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cancer is second leading cause of death worldwide. The psychological issues are related to all stages of the disease affecting outcome of treatment and overall quality of life. The study evaluated the effectiveness of yoga counselling among prostate cancer patients on their quality of life and psychological outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date February 25, 2017
Est. primary completion date January 5, 2017
Accepts healthy volunteers No
Gender Male
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria:

- Primary diagnosis of Prostate Cancer

- Sign a consent form allowing related information to be included in this research.

Exclusion Criteria:

- Have pre-existing diagnosed psychiatric conditions

- Currently taking psychotropic medications

- Have been diagnosed with cancer other than prostate cancer

- Evidence of active substance abuse.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Counselling based on yoga
Counseling sessions were given as one-on-one and group to patients based on yoga philosophy and therapy.
Drug:
Chemotherapy
Usual Care group had standard chemotherapy regimens

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
NMP Medical Research Institute Warwick Research Services, UK

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety and Depression Depression and anxiety as assessed by Hospital Anxiety Depression Scale Change from baseline to 12 weeks
Secondary Quality of Life Quality of life as assessed by WHO quality of life-BREF Change from baseline to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Active, not recruiting NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A